DUBLIN--(BUSINESS WIRE)--Aug 20, 2018--The "Syndromic Multiplex Diagnostic Markets, Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Country, With Market Analysis, Executive Guides and Customization, 2019 to 2023 - Global Version" report has been added to ResearchAndMarkets.com's offering.

Are targeted tests for specific pathogens going to be obsolete? Will Infectious Disease testing move into the Physician's Office or even the Home?

Syndromic testing is proving itself in the market. Players are reporting double digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks.

The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time.

The report forecasts the market size out to 2023. In a special section the report looks at the numbers on how syndromic molecular diagnostics is replacing traditional panel based ordering of infectious disease tests.

Key Topics Covered

1. Introduction and Market Definition

2. The Infectious Diseases - Guide to the Pathogens

3. Industry Overview

4. Market Trends

5. Syndromic Testing Recent Developments

6. Profiles of Key Syndromic Testing Companies

7. Global Market Size

8. Global Market by Syndrome

9. Panel Testing Market - Volumes and Price Forecast with MDx Share


I. United States Medicare System: 2018 Clinical Laboratory Fees Schedule - National Limit and Midpoint

II. FDA Approved Microbial Tests

Companies Featured

Abbott Diagnostics (Alere) Accelerate Diagnostics Alveo Technologies Applied BioCode Atlas Genetics Aus Diagnostics BD Diagnostics Bio-Rad Laboratories Biocartis BioFire Diagnostics bioMerieux Bosch Healthcare Solutions GmbH Cepheid Curetis Diagenode Diagnostics Diasorin Fusion Genomics GenMark Dx Hologic Janssen Diagnostics Lexigene Luminex Mesa Biotech Mobidiag Nanomix Primerdesign Qiagen (Statdx) Quantumdx Roche Molecular Diagnostics Seegene Siemens Healthineers (Fast Track Diagnostics) T2 Biosystems Thermo Fisher Veramarx

For more information about this report visit https://www.researchandmarkets.com/research/48hl2g/global_syndromic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180820005467/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/20/2018 12:11 PM/DISC: 08/20/2018 12:11 PM